Impact of Gadolinium-enhancing (GD+) Lesions on No Evidence of Disease Activity (NEDA) Status in Subcutaneous Interferon Beta-1a (SC IFNβ-1a)-treated Patients

Saved in:
Bibliographic Details
Published inMultiple sclerosis and related disorders Vol. 26; pp. 239 - 240
Main Authors Freedman, M., Comi, G., Coyle, P.K., Aldridge, J., Marhardt, K., Kappos, L.
Format Journal Article
LanguageEnglish
Published Elsevier B.V 01.11.2018
Online AccessGet full text

Cover

More Information
ISSN:2211-0348
2211-0356
DOI:10.1016/j.msard.2018.10.035